VCP and uterine cancer: Mutations of PPP2R1A in uterine cancer affect oncogenic signaling and promote tumor cell growth [52], whereas EHHADH and ACAT1 are regulators of drug resistance in tumor cells [53,54]; however, the role of VCP in cancer is unclear.